Management of Premature Rupture of Membranes (PROM)

Definition

Diagnosis

Diagnostic Tests

Initial Evaluation After Confirmed PROM

1. Estimate duration of membrane rupture
2. Confirm gestational age (LMP, clinical history, ultrasound)
3. Assess fetal presentation and well-being (continuous CTG if viable)
4. Evaluate for labor, vaginal bleeding, and clinical chorioamnionitis
5. Ultrasound: fetal size, growth, residual amniotic fluid volume, fetal anomalies
6. GBS carrier status from recent culture (within 6 weeks) - if unavailable, use empiric or risk-factor-based prophylaxis
7. Send cultures: GBS, Chlamydia, N. gonorrhoeae, bacterial vaginosis

Management by Gestational Age

1. Term PROM (≥37 weeks)

• There is no substantial fetal benefit to expectant management at term
• Immediate induction of labor is recommended (typically with oxytocin)
• GBS prophylaxis as indicated
• Cesarean section reserved for standard obstetric indications (malpresentation, fetal distress, failed induction)
• ~90% of term PROM patients enter spontaneous labor within 24 hours

2. Late Preterm PROM (34-36+6 weeks)

• Delivery is generally indicated after 34 weeks
• Fetal lung maturity is usually adequate
• Risk of chorioamnionitis from prolonged expectant management outweighs the marginal benefit of further maturation
• GBS prophylaxis as indicated

3. Preterm PROM (24-33+6 weeks) - Expectant/Conservative Management

Contraindications to Conservative Management

• Clinical chorioamnionitis (fever >38°C, uterine tenderness, fetal/maternal tachycardia, purulent fluid)
• Non-reassuring fetal status
• Placental abruption with significant hemorrhage
• Umbilical cord prolapse

Components of Conservative Management

• Betamethasone 12 mg IM × 2 doses 24 hours apart (or dexamethasone 6 mg IM × 4 doses 12 hours apart)
• Indicated at 24-34 weeks; consider at 34-36+6 weeks (late preterm)
• Accelerates fetal lung maturation, reduces risk of RDS, IVH, NEC
• Administer even in the presence of infection, as benefits outweigh risks

• Prolong the latent period (time from membrane rupture to onset of labor)
• Reduce maternal and neonatal infection risk
• NICHD/ACOG Regimen:
  • IV Ampicillin 2g q6h + IV Erythromycin 250 mg q6h × 48 hours, then
  • Oral Amoxicillin 250 mg q8h + Oral Erythromycin 333 mg q8h × 5 days
• Avoid amoxicillin-clavulanate (Augmentin) - associated with increased risk of neonatal necrotizing enterocolitis
• Alternatives if penicillin-allergic: azithromycin-based regimens

• NOT routinely recommended for long-term tocolysis in pPROM
• Short-term tocolysis (24-48 hours) may be used to allow corticosteroid administration and maternal transport to a tertiary center
• No benefit shown for extended tocolysis; may mask signs of chorioamnionitis

• Recommended at <32 weeks when delivery appears imminent
• Reduces risk of cerebral palsy and periventricular leukomalacia

• IV Penicillin G (first line) or IV Ampicillin during active labor
• Based on culture status or empiric if unavailable

• Prolonged bed rest increases DVT risk
• Leg exercises, compression stockings, sequential compression devices
• Permissive modified activity preferred over strict bed rest

Monitoring During Conservative Management

• Daily/continuous fetal monitoring (CTG)
• Maternal vital signs for signs of chorioamnionitis (fever, tachycardia, uterine tenderness)
• Serial CBC, CRP
• Ultrasound for amniotic fluid index, fetal growth, and well-being
• Patient should be managed in a facility with NICU capability and ability for emergent delivery

4. Previable PROM (<22-23 weeks)

• Extremely poor prognosis - fetal death/loss rate ~30% on average (14% if PROM <22 weeks, 58% at 22-24 weeks)
• Options are:
  1. Termination of pregnancy
  2. Expectant management - acknowledging the high risks of infection, cord prolapse, pulmonary hypoplasia, limb contractures (Potter sequence)
• Neonatal survival after conservative management is ~44% at ≤24 weeks
• Full counseling required regarding risks (chorioamnionitis 25-77%, maternal sepsis, fetal death)
• Pulmonary hypoplasia risk increases with very early rupture (<20 weeks) and prolonged oligohydramnios

Complications of PROM

Maternal

• Chorioamnionitis: 9% at term, 13-35% with pPROM, 25-77% with previable PROM
• Endometritis: 2-13%
• Placental abruption: 4-12%
• Maternal sepsis: 0.8%; death 0.14%

Fetal/Neonatal

• Umbilical cord compression (oligohydramnios)
• Umbilical cord prolapse (especially with malpresentation)
• Fetal death: 1-2% of conservatively managed cases
• Neonatal: RDS, IVH, NEC, sepsis (neonatal sepsis is 2× more common after pPROM vs. preterm labor without PROM)
• Long-term: cerebral palsy, periventricular leukomalacia, chronic lung disease, neurodevelopmental impairment
• Pulmonary hypoplasia with very early PROM (<20 weeks)
• Limb contractures (deformation sequence)

Summary Algorithm

PROM confirmed
    ├── ≥37 weeks → Induce labor (oxytocin) + GBS prophylaxis
    ├── 34-36+6 weeks → Deliver; GBS prophylaxis; consider late preterm steroids
    ├── 24-33+6 weeks
    │   ├── Chorioamnionitis/fetal distress → Deliver immediately
    │   └── No contraindications → Conservative management:
    │         Corticosteroids + Latency antibiotics + MgSO4 (<32 wks)
    │         + Fetal monitoring + Thromboprophylaxis
    └── <22-23 weeks → Counsel + offer expectant management vs. termination

Recent Evidence Note: A 2024 systematic review on periviable PROM (PMID: 38593987) confirms high rates of maternal and neonatal morbidity with conservative management before 24 weeks, consistent with the guidance above. No major management changes from current ACOG guidelines were identified in recent meta-analyses.